Director/PDMR Shareholding

RNS Number : 4345H

Dechra Pharmaceuticals PLC

03 December 2020

 

3 December 2020

Dechra^® Pharmaceuticals PLC

(Dechra or the Company)

LEI: 213800J4UVB5OWG8VX82

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Exercise of SAYE options:

Dechra Pharmaceuticals PLC announces that on 2 December 2020  Ian Page (PDMR) exercised options, under the Dechra Pharmaceuticals PLC Save As Year Earn Scheme, over 1,093 ordinary shares of 1p each (Ordinary Shares) at an exercise price of £16.46 per share.

Following this acquisition, Ian Page's beneficial interest in the Company is 340,012 shares (0.314% of the current issued share capital).

Dechra Pharmaceuticals PLC announces that on 2 December 2020  Paul Sandland (PDMR) exercised options, under the Dechra Pharmaceuticals PLC Save As Year Earn Scheme, over 1,093 ordinary shares of 1p each (Ordinary Shares) at an exercise price of £16.46 per share. He subsequently transferred the shares to his spouse, Adele Sandland for nil cost.

Following this acquisition, Paul Sandland's beneficial interest in the Company is 7,611 shares (0.007% of the current issued share capital).

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Forms

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Ian Page
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Exercise of 1,093 options under the Company's Save As You Earn Scheme
c)	Price(s) and volumes(s)	Price(s) £16.46	Volume(s) 1,093
d)	Aggregated information -  Aggregate volume -  Price	1,093 £17,990.78
e)	Date of the transaction	2020.12.2
f)	Place of the transaction	Outside a trading venue

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Paul Sandland
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Exercise of 1,093 options under the Company's Save As You Earn Scheme
c)	Price(s) and volumes(s)	Price(s) £16.46	Volume(s) 1,093
d)	Aggregated information -  Aggregate volume -  Price	1,093 £17,990.78
e)	Date of the transaction	2020.12.2
f)	Place of the transaction	Outside a trading venue

 

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Paul Sandland
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Transfer of 1,093 Ordinary Shares to his spouse for nil cost
c)	Price(s) and volumes(s)	Price(s) £0	Volume(s) 1,093
d)	Aggregated information -  Aggregate volume -  Price	1,093 £0
e)	Date of the transaction	2020.12.02
f)	Place of the transaction	Outside a trading venue

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Adele Sandland
2.	Reason for the notification
a)	Position/status	Person Close Associated with Paul Sandland (Director/PDMR)
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Receipt of 1,093 Ordinary Shares from her spouse for nil cost
c)	Price(s) and volumes(s)	Price(s) £0	Volume(s) 1,093
d)	Aggregated information -  Aggregate volume -  Price	1,093 £0
e)	Date of the transaction	2020.12.02
f)	Place of the transaction	Outside a trading venue

For further information, please contact:

Melanie Hall, Company Secretary 

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHKKNBQCBDKKBK